EP3604316 - SYNTHESIS OF BORONATE SALTS [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 03.11.2023 Database last updated on 03.09.2024 | |
Former | Grant of patent is intended Status updated on 13.06.2023 | ||
Former | Examination is in progress Status updated on 19.05.2023 | ||
Former | Grant of patent is intended Status updated on 09.01.2023 | ||
Former | Examination is in progress Status updated on 18.02.2022 | ||
Former | Request for examination was made Status updated on 07.08.2020 | ||
Former | The application has been published Status updated on 03.01.2020 | Most recent event Tooltip | 02.08.2024 | Lapse of the patent in a contracting state New state(s): PT, SK | published on 04.09.2024 [2024/36] | Applicant(s) | For all designated states Melinta Therapeutics, Inc. 389 Interpace Parkway, Suite 450 Parsippany, NJ 07054 / US | [2023/45] |
Former [2021/23] | For all designated states Melinta Therapeutics, Inc. 44 Whippany Road Suite 280 Morristown, NJ 07960 / US | ||
Former [2020/06] | For all designated states Rempex Pharmaceuticals, Inc. 300 TriState International, Suite 272 Lincolnshire, IL / US | Inventor(s) | 01 /
HECKER, Scott 4802 Rancho Viejo Dr. Del Mar, CA 92014 / US | 02 /
BOYER, Serge 5112 Castle Hills Drive San Diego, CA 92109 / US | [2020/06] | Representative(s) | Heller, Benjamin Henry, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [2020/06] | Application number, filing date | 19186092.3 | 30.04.2015 | [2020/06] | Priority number, date | US201461988690P | 05.05.2014 Original published format: US 201461988690 P | [2020/06] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3604316 | Date: | 05.02.2020 | Language: | EN | [2020/06] | Type: | B1 Patent specification | No.: | EP3604316 | Date: | 06.12.2023 | Language: | EN | [2023/49] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 27.09.2019 | Classification | IPC: | C07F5/04, C07F5/02, A01N55/08 | [2020/06] | CPC: |
C07F5/025 (EP,US);
A01N55/08 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/37] |
Former [2020/06] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | SYNTHESE VON BORONATSALZEN | [2020/06] | English: | SYNTHESIS OF BORONATE SALTS | [2020/06] | French: | SYNTHÈSE DE SELS DE BORONATE | [2020/06] | Examination procedure | 05.08.2020 | Amendment by applicant (claims and/or description) | 05.08.2020 | Examination requested [2020/37] | 05.08.2020 | Date on which the examining division has become responsible | 21.02.2022 | Despatch of a communication from the examining division (Time limit: M04) | 01.07.2022 | Reply to a communication from the examining division | 10.01.2023 | Communication of intention to grant the patent | 16.05.2023 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 14.06.2023 | Communication of intention to grant the patent | 24.10.2023 | Fee for grant paid | 24.10.2023 | Fee for publishing/printing paid | 24.10.2023 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP15788682.1 / EP3140310 | Divisional application(s) | EP23214076.4 / EP4356736 | Fees paid | Renewal fee | 11.11.2019 | Renewal fee patent year 03 | 11.11.2019 | Renewal fee patent year 04 | 11.11.2019 | Renewal fee patent year 05 | 27.04.2020 | Renewal fee patent year 06 | 27.04.2021 | Renewal fee patent year 07 | 27.04.2022 | Renewal fee patent year 08 | 27.04.2023 | Renewal fee patent year 09 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CZ | 06.12.2023 | EE | 06.12.2023 | HR | 06.12.2023 | LV | 06.12.2023 | NL | 06.12.2023 | RO | 06.12.2023 | RS | 06.12.2023 | SE | 06.12.2023 | SK | 06.12.2023 | SM | 06.12.2023 | BG | 06.03.2024 | NO | 06.03.2024 | IS | 06.04.2024 | PT | 08.04.2024 | [2024/36] |
Former [2024/35] | CZ | 06.12.2023 | |
EE | 06.12.2023 | ||
HR | 06.12.2023 | ||
LV | 06.12.2023 | ||
NL | 06.12.2023 | ||
RO | 06.12.2023 | ||
RS | 06.12.2023 | ||
SE | 06.12.2023 | ||
SM | 06.12.2023 | ||
BG | 06.03.2024 | ||
NO | 06.03.2024 | ||
IS | 06.04.2024 | ||
Former [2024/34] | EE | 06.12.2023 | |
HR | 06.12.2023 | ||
LV | 06.12.2023 | ||
NL | 06.12.2023 | ||
RS | 06.12.2023 | ||
SE | 06.12.2023 | ||
SM | 06.12.2023 | ||
BG | 06.03.2024 | ||
NO | 06.03.2024 | ||
IS | 06.04.2024 | ||
Former [2024/33] | HR | 06.12.2023 | |
LV | 06.12.2023 | ||
NL | 06.12.2023 | ||
RS | 06.12.2023 | ||
SE | 06.12.2023 | ||
SM | 06.12.2023 | ||
BG | 06.03.2024 | ||
NO | 06.03.2024 | ||
IS | 06.04.2024 | ||
Former [2024/32] | HR | 06.12.2023 | |
LV | 06.12.2023 | ||
NL | 06.12.2023 | ||
RS | 06.12.2023 | ||
SE | 06.12.2023 | ||
BG | 06.03.2024 | ||
NO | 06.03.2024 | ||
IS | 06.04.2024 | ||
Former [2024/26] | HR | 06.12.2023 | |
LV | 06.12.2023 | ||
NL | 06.12.2023 | ||
RS | 06.12.2023 | ||
SE | 06.12.2023 | ||
BG | 06.03.2024 | ||
NO | 06.03.2024 | ||
Former [2024/25] | HR | 06.12.2023 | |
RS | 06.12.2023 | ||
SE | 06.12.2023 | ||
BG | 06.03.2024 | ||
NO | 06.03.2024 | ||
Former [2024/21] | BG | 06.03.2024 | Documents cited: | Search | [A]WO2012021455 (REMPEX PHARMACEUTICALS INC [US], et al) | by applicant | WO8705297 |